Perq islet cell transplant
Percutaneous islet cell transplant, an experimental diabetes treatment injecting insulin-producing cells into the liver, lacks established Medicare pricing data, making bill verification essential given the procedure's investigational status.
About the analyst
Kevin Nyk analyzes hospital pricing data at BillRazor Research. He specializes in Medicare reimbursement patterns and chargemaster pricing across U.S. hospitals. Expertise: hospital pricing, Medicare rates, chargemaster analysis.
Percutaneous islet cell transplant involves inserting insulin-producing cells from a donor pancreas directly into a patient's liver through a minimally invasive needle procedure. This experimental treatment typically serves patients with severe Type 1 diabetes who experience frequent dangerous blood sugar episodes. As a Category III CPT code, 0584T requires prior authorization from most payers and may face coverage denials due to its investigational status.
Non-facility rate
$99
Office setting benchmark
Data sources
2
21 data points
What this procedure costs across different settings
The same procedure can cost very different amounts depending on where it's performed. These are the Medicare-allowed amounts — what hospitals actually charge can be 3-10x higher.
| Setting | Medicare rate | vs lowest |
|---|---|---|
| Non-facility (office) | $99 | Lowest |
Got a bill with CPT 0584T?
Upload your bill and our AI compares every line item against these exact benchmark rates. Free analysis in 60 seconds — you only pay if we find savings.
About this data
Rates shown are from the 2026 Medicare Physician Fee Schedule, Hospital Outpatient Prospective Payment System (OPPS), Ambulatory Surgery Center Payment System, Clinical Laboratory Fee Schedule, Durable Medical Equipment Fee Schedule, and CMS Inpatient Prospective Payment System (DRG weights). Regional adjustments use CMS Geographic Practice Cost Indices (GPCI). Hospital charges are from CMS Hospital Price Transparency machine-readable files. All data is publicly available under federal law (45 CFR Part 180).
This data is for informational purposes only and does not constitute medical or financial advice. Actual costs depend on insurance coverage, negotiated rates, and individual circumstances.
Data: Medicare Physician Fee Schedule, CMS Inpatient PPS (IPPS), Outpatient PPS (OPPS), ASC Payment System, Clinical Lab Fee Schedule (CLFS), National Average Drug Acquisition Cost (NADAC). FY 2024 data. All publicly available from CMS.
Methodology: Facility rate applies when the procedure is performed in a hospital or ASC. Non-facility rate applies in a physician office. GPCI adjustments reflect regional cost-of-living differences.
This information is for educational purposes only and is not medical, financial, or legal advice. Actual costs depend on your insurance and provider. We recommend verifying costs directly with your provider. Full methodology · Terms of use